Leukemia Posts on Medivizor
Navigation Menu

Leukemia Posts on Medivizor

Evaluating the use of ibrutinib with bendamustine and rituximab treatment in unresponsive chronic lymphocytic leukemia

Posted by on Dec 8, 2018 in Leukemia | 0 comments

In a nutshell This study looked at the safety and effectiveness of ibrutinib (Imbruvica) added to bendamustine (Treanda) and rituximab (Rituxan) in the treatment of unresponsive chronic lymphocytic leukemia. Researchers found that this treatment improved survival in these patients. Some background Chronic lymphocytic leukemia (CLL) is a...

Read More

The effect of ibrutinib on white blood cell count in CLL

Posted by on Dec 6, 2018 in Leukemia | 0 comments

In a nutshell This study wanted to look at the effect of ibrutinib (Imbruvica) on white cell count (immune cells) in patients with chronic lymphocytic leukemia. Researchers found that increases in white cell count during ibrutinib treatment were normal and did not indicate poor outcomes in these patients. Some background Chronic lymphocytic leukemia...

Read More

Evaluating the safety and effectiveness of ponatinib for CML

Posted by on Dec 6, 2018 in Leukemia | 0 comments

In a nutshell The study looked at the safety and effectiveness of ponatinib (Iclusig) in the treatment of chronic myeloid leukemia (CML). Researchers found that ponatinib was safe and effective in previously treated patients with CML. Some background Chronic myeloid leukemia is a type of cancer of the bone marrow. This can lead to abnormal immune...

Read More

Do ACE inhibitors help with anthracycline-induced cardiotoxicity in leukemia and lymphoma?

Posted by on Dec 6, 2018 in Leukemia | 0 comments

In a nutshell This study aimed to investigate if enalapril influences anthracycline-induced cardiotoxicity in children with leukemia and lymphoma. This study concluded that enalapril has a role in reducing anthracycline-induced cardiotoxicity in these patients. Some background Anthracyclines are a class of chemotherapy drugs that can be used for...

Read More

The safety and effectiveness of bosutinib in patients with chronic myeloid leukemia

Posted by on Nov 30, 2018 in Leukemia | 0 comments

In a nutshell This study looked at the safety and effectiveness of bosutinib (Bosulif) in the treatment of chronic myeloid leukemia (CML). Researchers found that bosutinib was effective in patients who have failed other similar drug treatments. Some background Chronic myeloid leukemia (CML) is a cancer of the bone marrow. This can lead to abnormal...

Read More

The impact of tyrosine kinase inhibitors on the survival of patients with chronic myeloid leukemia

Posted by on Nov 27, 2018 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the outcomes of patients with chronic myeloid leukemia who were treated with tyrosine kinase inhibitors. This study concluded that this treatment increased survival for new and older CML cases. Some background Imatinib (Gleevec) was the first tyrosine kinase inhibitor (TKI) used to treat chronic myeloid...

Read More

Adding Lomustine to chemotherapy for acute myeloid leukemia for elderly patients

Posted by on Nov 26, 2018 in Leukemia | 0 comments

In a nutshell This study looked at the safety and effectiveness of adding lomustine (Gleostine) to chemotherapy in the treatment of acute myeloid leukemia in patients aged over 60. Researchers found that this treatment improved outcomes for elderly patients with AML. Some background Acute myeloid leukemia (AML) is a cancer of the bone marrow....

Read More

Adding inotuzumab ozogamicin with or without blinatumomab to chemotherapy for ALL.

Posted by on Nov 26, 2018 in Leukemia | 0 comments

In a nutshell This study looked at the effectiveness of adding inotuzumab ozogamicin (Besponsa) and blinatumomab (Blincyto) to low-intensity chemotherapy in the treatment of ALL. Researchers found that this combination of treatment was effective in these patients. Some background Acute lymphoblastic leukemia (ALL) is a cancer of the bone marrow. This...

Read More

Use of specific T-cells in the treatment of ALL

Posted by on Nov 25, 2018 in Leukemia | 0 comments

In a nutshell This study looked at the use of specific T-cells to treat acute lymphoblastic leukemia. Researchers found that using these cells was effective in the treatment of these patients. Some background Acute lymphoblastic leukemia (ALL) is a type of cancer of the bone marrow. This can lead to abnormal cells in the immune system. It is often...

Read More

Is blinatumomab safe and effective in the treatment of ALL?

Posted by on Nov 25, 2018 in Leukemia | 0 comments

In a nutshell This study looked at the safety and effectiveness of blinatumomab (Blincyto) in the treatment of unresponsive acute lymphoblastic leukemia (ALL). Researchers found that blinatumomab was safe and effective in the treatment of these patients. Some background Acute lymphoblastic leukemia is a type of cancer of the bone marrow. This can lead...

Read More